Accelerate Diagnostics, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Accelerate Diagnostics reported its third quarter 2024 results, showing a decrease in net sales and a net loss, while also announcing a strategic review process.
Accelerate Diagnostics reports a net loss of $25.8 million for the first half of 2024, highlighting ongoing financial challenges and the need for additional funding.
Accelerate Diagnostics reported a net loss of $14.2 million for the first quarter of 2024, while navigating ongoing financial challenges and focusing on product development.